AcuFocus, maker of the Kamra small-aperture intracorneal inlay, has added Daniel S. Durrie, MD, Richard L. Lindstrom, MD, and John A. Vukich, MD, to its advisory leadership team, according to a company news release.
“We look forward to working closely with our vast team … to ensure we meet our internal R&D, commercial, clinical and regulatory objectives,” Jim Mazzo, executive chairman and CEO for AcuFocus, said in the release.
Vukich was appointed chairman of the AcuFocus medical advisory board and will oversee efforts to advance the Kamra inlay via clinical guidance to improve outcomes and refine the procedure.
Durrie will step aside from his former position as chairman of the AcuFocus medical advisory board to lead the premarket approval team, focusing on cooperation with the U.S. Food and Drug Administration.
Lindstrom will help lead the scientific advisory board to further small-aperture technologies and their supporting diagnostics.